Find Academic Supervisors

Aaron LeeView profile

Assistant Professor

• Acute Coronary Syndrome
• Surgical Repair
• Oligodendrocyte Precursor Cells
• +5 more

Aaron Lee, MD, MA, serves as an Assistant Professor in the Department of Medicine, Division of Cardiology. His academic work centers on advancing interventional cardiology and diagnostic approaches for acute cardiac conditions through rigorous clinical research. Education : Holds dual qualifications including a Doctor of Medicine (MD) and Master of Arts (MA), though specific institutions and graduation dates remain unreported in available materials. Research Focus : Dr. Lee's investigations span critical cardiology domains: Acute Coronary Syndrome diagnostics and management protocols Chronic Kidney Disease interactions with cardiac biomarkers High-sensitivity Troponin interpretation in comorbid populations Coronary intervention device safety and complications Coronary vasospasm mechanisms and autonomic nervous system links Unexpected intersections with cellular neuroscience including Oligodendrocyte Precursor Cells Publication Trends : His 2021-2025 output reveals concentrated efforts on real-world interventional challenges, particularly device complications (Wolverine Cutting Balloon), vasospastic conditions, and transnational registry analyses. Work consistently addresses diagnostic dilemmas in complex patients while leveraging international datasets for robust clinical insights. Collaborative Network : Research demonstrates extensive cross-institutional partnerships, with frequent co-authorship patterns indicating active participation in multi-center cardiac research initiatives across cardiology subspecialties.

• Pulmonary Medicine
• Critical Care Medicine
• Pediatrics
• +3 more

Kara Goss, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, with a secondary appointment in Pediatrics. She leads a multidisciplinary research lab studying how premature birth impacts lifelong heart and lung health, focusing on cardiovascular phenotypes, pulmonary arterial hypertension, and developmental origins of disease. Baylor University (B.S., summa cum laude) Baylor College of Medicine (M.D.) Combined Internal Medicine/Pediatrics Residency, Indiana University Pulmonary & Critical Care Fellowship Clinical Research Certificate, University of Wisconsin Her research employs advanced imaging modalities (4D flow MRI, PET/MRI) to investigate structural and functional cardiac adaptations in preterm survivors, linking these to metabolic and autonomic dysregulation. Recent publications highlight impaired ventricular-vascular coupling, fibrosis, and exercise capacity in this population. Dr. Goss actively contributes to professional societies including the American Thoracic Society, American College of Chest Physicians, and Pulmonary Hypertension Association. She co-chairs the Women in Pulmonary Critical Care "Lung Ladies" Committee and participates in curriculum development and physician-scientist training initiatives.

• Neuropsychology
• Cognitive Rehabilitation
• Parkinson's Disease
• +4 more

Dr. Olaia Lucas Jiménez is a Professor at the Universidad de Deusto , School of Health Sciences, Department of Psychology. She has coordinated the Master Universitario en Neuropsicología Clínica and served as Secretary of the Faculty of Health Sciences since 2017. Her academic training includes a PhD in Psychology (Cum Laude, 2019-2020), a specialization in Neuropsychology (2015), and a postgraduate in Health Psychology (2017). Graduated with Honors Program distinction (2010-2014) Erasmus exchange at National University of Ireland, Galway (2012-2013) Her research focuses on neuropsychological aspects of Parkinson's disease , particularly non-motor symptoms , brain connectivity , and cognitive rehabilitation . She explores retinal biomarkers , quality of life predictors , and neuroimaging techniques for diagnosing and monitoring neurodegenerative conditions. Recent trends in her publications highlight multimodal neuroimaging to study structural/functional brain changes in Parkinson's disease, sex differences in cortical thickness, and visual dysfunction as a cognitive impairment predictor. Her work often integrates resting-state connectivity and retinal thinning analysis to identify early disease markers. Ignacio Ellacuría Award for best doctoral thesis (2019-2020) Part of the Neuropsicología de los Trastornos Médicos Severos research team recognized by the Basque Government She has lectured on Psychology, Education, and Social Work degrees, and collaborated with the Fatigue Research Group and Feinstein Institute for Medical Research (New York). Her 15 most recent articles emphasize non-motor cognitive biomarkers , rehabilitation outcomes , and multisite neuroimaging harmonization .

Patric BachView profile

Professor

• Predictive Processing
• Social Perception
• Action Observation
• +5 more

Patric Bach is a Professor and Chair in Psychology at the University of Aberdeen, affiliated with the School of Psychology. He leads the Action Prediction Lab, focusing on predictive mechanisms in social perception, action observation, and human-robot interaction. His research employs Bayesian models, EEG/fMRI, and behavioral paradigms to investigate how prior knowledge shapes perception and prediction. His core research examines predictive processing in social contexts, including: (1) how expectations bias action perception and visual perspective-taking, (2) neural mechanisms underlying motor imagery and interoceptive illusions, and (3) applications in human-robot collaboration (e.g., robot motion perception and perspective-taking). Key themes include Bayesian hypothesis-testing, teleological action interpretation, and effect-based action control. Bach's recent publications emphasize multisensory integration in robotics, predictive biases in pain/interoception, and replications of social perception effects. Trends show increasing focus on computational modeling, embodied cognition in synthetic agents, and clinical implications of predictive processing. He has secured significant funding, including a £462,995 Leverhulme Trust grant (2020–2023) for neurocognitive studies of social prediction. He directs interdisciplinary projects with collaborators at Plymouth, Bangor, and international institutions, often involving EEG/fMRI and human-robot interaction paradigms.

• Neuroscience
• Synaptic Transmission
• Cell Signaling
• +3 more

Dr. Mark Graham is a Senior Lecturer at the Faculty of Medicine and Health, University of Sydney, and serves as Group Leader at the Children’s Medical Research Institute. His research focuses on the molecular mechanisms of synaptic transmission and neurological diseases, bridging biochemical pathways with therapeutic discovery. Education: Honours in Medical Science (Westmead), PhD (Children’s Medical Research Institute) Research Interests: Dr. Graham investigates phosphorylation-based cellular signaling to identify pathways and biomarkers in synaptic transmission and diseases like epilepsy, autism, and schizophrenia. His group employs mass spectrometry, biochemical assays, and functional studies to map regulatory mechanisms. Article Trends: Recent work spans proteostasis in Tau immunotherapy, ketogenic diet effects in Kabuki syndrome, dysferlinopathy prevention via gene expression, and synaptic condensate formation in neurodegeneration. These studies integrate proteomics, neurogenetics, and synaptic biology. Grants: His projects have been supported by NHMRC, MRFF, ARC, and institutional grants, including RTTomics for Rett syndrome and ALPK1 dysfunction in retinal diseases. Labs & Collaborations: The Synapse Proteomics group collaborates with institutions like the University of Sydney Brain and Mind Centre, leveraging cortical organoids, mouse models, and phosphoproteomics for interdisciplinary discoveries.

Khashayar DashtipourView profile

Professor

• Neurology
• Parkinson's Disease Research
• Movement Disorders
• +5 more

Dr. Khashayar Dashtipour, MD, PhD, serves as Professor of Neurology in the School of Medicine and Associate Professor of Pharmacy Practice in the School of Pharmacy at Loma Linda University. He also holds an Associate Professor position in the Basic Sciences Pharmacology Division within the School of Medicine. His academic career spans multiple disciplines at the intersection of neurology and pharmacology, with a focus on movement disorders and therapeutic interventions. Dr. Dashtipour's research interests center on Parkinson's disease, movement disorders including dystonia and essential tremor, and the therapeutic applications of botulinum toxin. His work encompasses clinical trials, pharmacological interventions, and innovative treatment approaches for neurological conditions. He has made significant contributions to understanding the mechanisms and management of spasticity, sialorrhea, and other movement disorder symptoms. Analysis of his recent publications reveals a strong focus on botulinum toxin therapies across multiple indications, with particular attention to dosing protocols, safety profiles, and comparative effectiveness. His research also extends to Parkinson's disease therapeutics, genetic factors in movement disorders, and health disparities in neurological care. The publication trend shows consistent output with increasing emphasis on precision medicine approaches and real-world evidence. Dr. Dashtipour has served as Principal Investigator on numerous clinical trials, including NIH-funded studies and industry-sponsored research with major pharmaceutical companies. His current projects include investigations into DNA methylation patterns in Parkinson's disease, novel treatments for cervical dystonia, and studies examining the relationship between spirituality and Parkinson's disease outcomes. His research program demonstrates a comprehensive approach to movement disorders, spanning basic science investigations, clinical trials, and translational research aimed at improving patient outcomes through evidence-based therapeutic interventions.

Cameron MetcalfView profile

Researcher

• Epilepsy
• Pain Management
• Neuropeptide Systems
• +3 more

Cameron Metcalf, PhD, is a Researcher in the Department of Pharmacology and Toxicology at the University of Utah's College of Pharmacy. He serves as the Associate Director of the Anticonvulsant Drug Development (ADD) Program and Co-Investigator for NIH/NINDS grants, with expertise in preclinical drug development for epilepsy and pain. His lab focuses on three pillars: novel therapies for epilepsy, understanding SUDEP mechanisms, and developing biomarkers to reduce epilepsy-related mortality. Education: BS in Biology, Human Development and Family Studies - University of Utah PhD in Pharmacology and Toxicology - University of Utah Dr. Metcalf's research spans neuropeptide-based treatments, epilepsy mortality pathways, and translational models for drug screening. He has advanced rodent models for NIH's Epilepsy Therapy Screening Program and collaborated with pharmaceutical companies to develop compounds now in clinical trials. His work on galanin analogs explores novel anticonvulsant mechanisms and combination therapies. Publications highlight expertise in epilepsy pharmacology, SUDEP pathophysiology, and digital therapeutics. The ADD Program, funded continuously since 1975, evaluates 800-1000 compounds annually and provided training for students in neurobiology, pharmacology, and clinical research.

Ann SchreihoferView profile

Professor

• Neurophysiology
• Autonomic Nervous System
• Blood Pressure Regulation
• +6 more

Professor Ann Schreihofer is affiliated with the University of North Texas Health Science Center in the College of Biomedical and Translational Sciences , Department of Physiology and Anatomy . With a B.S. in Psychology from Emory University and a Ph.D. in Neuroscience from the University of Pittsburgh, she specializes in neurophysiology education and research on brain-cardiovascular interactions. Neurophysiology pedagogy (graduate programs) Baroreflex mechanisms in disease Multidisciplinary obesity research Her research portfolio spans cardiovascular neuroscience , metabolic syndrome , and Alzheimer’s disease , focusing on neural regulation of blood pressure and obesity-related brain changes. Articles highlight experimental models like obese Zucker rats and sinoaortic denervation to study autonomic dysfunction. Scientific recognition includes Election to American Physiological Society Council Leadership on NIH and AHA grant review panels She mentors graduate/postdoctoral trainees and serves on institutional committees for research integrity and academic advancement.

• Multiple Sclerosis
• Neuromyelitis Optica Spectrum Disorder
• MOG Antibody-Associated Disease
• +4 more

Silvia Messina is an Honorary Senior Clinical Lecturer in General Neurology and Acute General Neurology at the University of Oxford Medical School. She serves as an honorary consultant for the Multiple Sclerosis Clinical Trials Unit and works as a neurology consultant at Frimley Health Foundation Trust, providing neurological care for MS and acute neurology patients. Dr. Messina graduated and trained as a neurologist at the University of Catania, Italy, where she also served as a clinical lecturer for the Multiple Sclerosis service. She has a background in neuroimmunology and previously worked as a research fellow at Harvard Medical School. She later served as the clinical NMO fellow in the Oxford NMO service, managing one of the largest global cohorts of NMOSD-AQP4, MOGAD, and seronegative NMOSD patients. Her research focuses on the use of non-conventional MRI in NMOSD and MOGAD to define their pathogenesis and explore clinical and laboratory correlates. She actively supports research within the NMO service and is involved in developing a clinical-imaging platform that integrates imaging from multiple sites. Her work bridges neuroimaging, clinical research, and neuroimmunology to advance understanding of demyelinating diseases. Dr. Messina participates in several international collaborations, including the International Panel for NMO Diagnosis (IPND) task force as a neuroimaging expert, contributing to the development of the 2025 NMOSD diagnostic criteria. She is also part of the European NMO (MEDEN) group and has been a member of the MAGNIMS network since 2016, contributing to collaborative MRI studies. As a member of the Oxford Brain Bank Access and Management Committees, she represents demyelinating diseases. She serves as a bedside tutor, OSCE examiner, and facilitator in 'patient-expert sessions' for the neuroscience teaching faculty at the University of Oxford Medical School since August 2023.

Ferdinando Carlo Maria CananziView profile

Associate Professor

• Soft Tissue Sarcomas
• Gastrointestinal Stromal Tumors (GIST)
• Melanoma
• +4 more

Ferdinando Carlo Maria Cananzi is an Associate Professor of Surgery at Humanitas University , specializing in General Surgery with a focus on oncological applications. He serves as Section Head at the IRCCS Humanitas Research Hospital in the Sarcoma, Melanoma and Rare Tumors Surgery Unit. Education: Graduated from Catholic University of the Sacred Heart in Rome Specialization: General Surgery (2013) Training: Clinical Fellow at Royal Marsden Hospital (2012-2013) Research Interests center on soft tissue sarcomas, gastrointestinal stromal tumors (GIST), melanomas, and complex abdominal/pelvic tumors. His work explores: Immunological interactions in sarcoma progression Vascular resection techniques in retroperitoneal tumors Multidisciplinary treatment approaches Tumor microenvironment dynamics Key Publications include studies on: Complement system's role in sarcoma immunosuppression Neutrophil-T cell interactions in tumor resistance Margin analysis in sacral chordoma Angiosarcoma treatment guidelines Professional Activities include: Head of Sarcoma/Melanoma Unit at Humanitas Collaboration with Italian Sarcoma Group Contributions to multidisciplinary cancer treatment protocols

Martin HruskaView profile

Assistant Professor

• Synaptic Plasticity
• Molecular Neuroscience
• Super-Resolution Microscopy
• +3 more

Martin Hruska is an Assistant Professor at the West Virginia University School of Medicine , affiliated with both the Department of Neuroscience and the Rockefeller Neuroscience Institute . His research focuses on synaptic biology in the central nervous system (CNS), emphasizing structural plasticity, molecular organization, and implications for neurological disorders. Research Domains : Nanoscale synaptic architecture, Synaptic plasticity mechanisms, Neurological disorder pathogenesis. Methodology : Integrates molecular/biochemical techniques with Stimulated Emission Depletion (STED) microscopy for super-resolution imaging. Key Questions : How are synaptic nano-domains established? How do AMPAR/NMDAR organize in synapses? How does synaptic organization affect cortical processing? Martin Hruska's publications (2007–2024) highlight his expertise in Ephrin-B3 signaling, PSD-95 anchoring, synaptic stability, and receptor organization in dendritic spines. His work bridges molecular neuroscience, neurodegenerative diseases, and advanced imaging technologies to address synaptic dysfunction in Alzheimer’s disease and other CNS pathologies.

• Mitochondrial Biology
• Neuromuscular Disorders
• Electron Microscopy
• +3 more

Tracey Davey is a Research Fellow at Newcastle University with an active 17-year publication record (2008-2025) in ultrastructural pathology and mitochondrial biology. Her work bridges veterinary and human medicine, focusing on neuromuscular disorders, retinal degeneration, and pancreatic pathology through advanced electron microscopy techniques. Her core research domains include: Mitochondrial dynamics in neurodegenerative and metabolic diseases Neuromuscular junction ultrastructure in equine and human disorders Retinal pigment epithelium pathology in age-related macular degeneration Quantitative electron microscopy for pancreatic stress assessment Species-specific neurotoxic mechanisms in snake venoms Analysis of her 2018-2025 publications reveals consistent methodological innovation in SBF-SEM and COX histochemistry for 3D mitochondrial mapping, with increasing focus on translational applications in mitochondrial myopathies, diabetic complications, and SARS-CoV-2 pathogenesis. Her collaborative work with Emeritus Professors Turnbull and Harris demonstrates deep integration within Newcastle's mitochondrial medicine research ecosystem. No scientific awards were documented in the source material. While student supervision details are absent, her role as consistent co-investigator on multi-author studies indicates significant mentorship contributions. No specific grant funding or laboratory leadership information was provided, though her methodological developments suggest ongoing institutional research support.

Shin KangView profile

Associate Professor

• Glial Biology
• Neural Regeneration
• CNS Diseases
• +5 more

Shin Kang, PhD is an Associate Professor at Temple University's Lewis Katz School of Medicine in the Department of Neural Sciences and the Center for Neural Development and Repair. His academic appointments reflect a dual commitment to both foundational neuroscience research and translational applications in neural repair mechanisms. Lewis Katz School of Medicine, Temple University Department of Neural Sciences Center for Neural Development and Repair Dr. Kang received his educational training through a rigorous neuroscience pathway: completing his PhD and Postdoctoral Fellowship in the Solomon H. Snyder Department of Neuroscience at Johns Hopkins University School of Medicine, preceded by a Master's in Molecular Biology and Bachelor's in Zoology from Seoul National University. This strong foundation in both basic science and specialized neuroscience prepared him for his current research focus. His research program centers on glial progenitor biology and oligodendrocyte abnormalities in CNS diseases , investigating cellular and molecular mechanisms underlying regenerative glial responses to central nervous system injury. Dr. Kang's laboratory explores how glial cells - particularly oligodendrocyte progenitors that behave like stem cells - contribute to CNS repair through proliferation, differentiation, and direct monitoring of neuronal activity via synapse formation. His work reveals critical neuron-glia signaling mechanisms that regulate regenerative behaviors in health and disease, with implications for numerous neurological disorders where progenitor-derived regeneration becomes misregulated. Analysis of Dr. Kang's publication record reveals a consistent focus on oligodendrocyte biology , neural regeneration , and CNS injury mechanisms over two decades. His research spans from fundamental cellular mechanisms to disease applications, particularly in amyotrophic lateral sclerosis and spinal cord injury contexts. The methodologies employed demonstrate technical sophistication including BAC transgenesis, in vivo cell fate tracing, cell-type specific functional manipulation, and molecular expression profiling in relevant mouse disease models. While no specific scientific awards are listed in the available documentation, Dr. Kang's research program represents a significant contribution to the field of neural repair mechanisms. His work has been published in high-impact journals including Nature Neuroscience, Cell Reports, and Journal of Neuroscience, indicating peer recognition of his scientific contributions. Dr. Kang's laboratory employs diverse molecular and genetic approaches to investigate regenerative mechanisms, utilizing mouse disease models to bridge basic science with potential therapeutic applications. His research program appears well-integrated within the neuroscience community, with frequent collaborations evident in his publication record, particularly with the Bergles laboratory at Johns Hopkins University.

Arto HautalaView profile

Associate Professor

• Remote Physiotherapy and Rehabilitation Technology
• Personalized Exercise Therapy
• Exercise Training Responses
• +3 more

Arto Hautala serves as Associate Professor of Physiotherapy and Rehabilitation at the University of Jyväskylä's Faculty of Sport and Health Sciences. He heads Finland's academic discipline of physiotherapy and directs the Physiotherapy Team. Hautala chairs the working group for Finland's exercise-based cardiac rehabilitation guideline and advises on national physical activity guidelines. From 2021-2024, he directed MOKUVE (a network of 11 universities for rehabilitation), and starting in 2025, he will lead FiRe (26 universities). He also advises Finland's National Sports Council through 2027. Hautala earned his doctorate in physiology from the University of Oulu, focusing on exercise and autonomic nervous system regulation. He then conducted post-doctoral research in human genomics at Louisiana's Pennington Biomedical Research Center, gaining expertise in molecular biology and genetic analysis techniques. Hautala's research explores technology-enhanced remote rehabilitation, personalized exercise therapy for disease prevention and management, and individual variability in exercise responses. He investigates autonomic dysfunction markers linked to cardiovascular mortality and seeks objective methods to quantify subjective pain. His work integrates physiology, biomechanics, and clinical practice to develop tailored rehabilitation strategies that improve patient outcomes across diverse health conditions. His recent publications demonstrate a focus on evidence-based rehabilitation interventions, including studies on sarcopenia in older adults, cardiac rehabilitation for atrial fibrillation, spinal cord injury outcomes, and musculoskeletal pain management. Hautala combines clinical trials with real-world observational data to evaluate technology-driven and personalized approaches. His Finnish-language publications address foundational topics like individual exercise responses and evidence-based practice, reflecting his commitment to both international and national scholarly discourse. As director of the Physiotherapy Team and Finland's national rehabilitation networks (MOKUVE until 2024 and FiRe from 2025), Hautala coordinates multidisciplinary collaborations across 26 universities. These initiatives integrate research, education, and clinical practice to advance rehabilitation science and policy, positioning him as a key architect of Finland's rehabilitation research infrastructure.

Katsu FunaiView profile

Associate Professor

• Lipid metabolism
• Mitochondrial energetics
• Bioenergetics
• +5 more

Katsu Funai is an Associate Professor of Nutrition and Integrative Physiology and an Adjunct Associate Professor of Biochemistry at the University of Utah. He directs the Funai Laboratory, established in 2013, and is affiliated with the Molecular Biology and Biological Chemistry Ph.D. programs. Education: B.S./M.S. – Boston University Ph.D. – University of Michigan Research Interests: The Funai group investigates how intracellular lipids—particularly mitochondrial membrane phospholipids—control cellular energetics and contribute to metabolic diseases. Using genetic and pharmacological models, the lab explores lipid remodeling in skeletal muscle, adipose tissue, liver, pancreatic β-cells, and kidney proximal tubules. Key themes include phosphatidylethanolamine (PE) metabolism, cardiolipin remodeling, lipid peroxidation, and the interface between membrane composition and oxidative phosphorylation efficiency. Recent work demonstrates that exercise and inactivity dynamically remodel the mitochondrial lipidome, altering respiratory enzyme activity and whole-body metabolic flexibility. The group is also dissecting how lipid-derived reactive species promote sarcopenia and how interventions that restore membrane homeostasis can mitigate age- and obesity-associated metabolic dysfunction. Funding & Support: Research in the Funai laboratory is currently supported by grants from the National Institutes of Health and the American Heart Association. Scientific Awards & Recognition: Although no specific awards are listed, Dr. Funai’s papers have been selected for journal covers (e.g., Nature Metabolism 2019) and are widely cited in the fields of metabolism and mitochondrial biology. Laboratory & Collaborations: The lab maintains active collaborations with investigators across the University of Utah, including Drs. Cox, Drummond, Rutter, and Neufer, and participates in multi-disciplinary training programs such as the Molecular Biology and Biological Chemistry Ph.D. tracks. Trainees and staff have access to state-of-the-art core facilities in metabolomics, lipidomics, mitochondrial physiology, and transgenic mouse models.